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https://doi.org/10.1186/s12939-020-01323-zRESEARCH Open AccessCoverage determinants of breast cancer
screening in Flanders: an evaluation of the
past decade
L. Ding1,2, S. Jidkova3,4, M. J. W. Greuter5,6, K. Van Herck3,4, M. Goossens4, P. Martens4, G. H. de Bock1* and
G. Van Hal2,4Abstract
Background: Breast cancer (BC) is the most common cancer in women in the developed world. In order to find
developing cancers in an early stage, BC screening is commonly used. In Flanders, screening is performed in and
outside an organized breast cancer screening program (BCSP). However, the determinants of BC screening
coverage for both screening strategies are yet unknown.
Objective: To assess the determinants of BC screening coverage in Flanders.
Methods: Reimbursement data were used to attribute a screening status to each woman in the target population
for the years 2008–2016. Yearly coverage data were categorized as screening inside or outside BCSP or no
screening. Data were clustered by municipality level. A generalized linear equation model was used to assess the
determinants of screening type.
Results: Over all years and municipalities, the median screening coverage rate inside and outside BCSP was 48.40%
(IQR: 41.50–54.40%) and 14.10% (IQR: 9.80–19.80%) respectively. A higher coverage rate outside BSCP was
statistically significantly (P < 0.001) associated with more crowded households (OR: 3.797, 95% CI: 3.199–4.508),
younger age, higher population densities (OR: 2.528, 95% CI: 2.455–2.606), a lower proportion of unemployed job
seekers (OR: 0.641, 95% CI: 0.624–0.658) and lower use of dental care (OR: 0.969, 95% CI: 0.967–0.972).
Conclusion: Coverage rate of BC screening is not optimal in Flanders. Women with low SES that are characterized
by younger age, living in a high population density area, living in crowded households, or having low dental care
are less likely to be screened for BC in Flanders. If screened, they are more likely to be screened outside the BCSP.
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Belgium is among the countries with the highest
female breast cancer (BC) incidence and mortality
worldwide [1]. In 2018, the age-standardized BC inci-
dence and mortality rate of Belgium women were
113.2/100,000 and 22.2/100,000 person-years, respect-
ively, which is higher than the estimate for the whole
Western European region (92.6 and 15.5/100,000
person-years, respectively) [1, 2]. While sufficient evi-
dence has indicated that mammography screening has
the potential to initiate early diagnosis and treatment
for BC and lower BC mortality, the effect of mammog-
raphy screening relies on the degree to which women
participate in screening [3].
In most of the high income countries, women are rec-
ommended to participate in an organized BC screening
program (BCSP), where quality is warranted by system-
atic quality control measures [4]. Outside this program,
with the aim to screen more of the eligible women,
spontaneous screening is also endorsed in some countries,
such as in Belgium [5], France [6] and Switzerland [7].
The coverage of BC screening, defined as the percentage
of screened women in the total eligible population within
the specific interval of routine screening [8], is an import-
ant indicator for the evaluation of the effectiveness of
screening [4, 9]. However, the average coverage rate in
2016 across OECD countries was only 57.4% [10]. As for
Flanders, the coverage rate of BCSP in 2017 was only 49
and 13% was screened outside the BCSP [11].
Many factors have previously been shown to be
associated with a reduced coverage level of BCSP. A
systematic review summarized that the barriers to BC
screening fell into three categories: 1) health care sys-
tem level barriers, such as lack of health care providers
and economic barriers; 2) social barriers, such as lack
of social support and cultural norms opposed to BC
screening;, and 3) individual level barriers, such as lack
of cancer knowledge and beliefs, negative expectations
of screening, and distrust of the medical system [12].
However in this review, the majority of the included
studies relied on self-reported data, studies with
random and convenience samples were pooled, and
evidence was only qualitatively synthesized. Many
other studies have also provided quantitative evidence
on these hampering factors. Among them, economic
related barriers were the most commonly studied
factors and results showed that low income [13],
crowded housing condition [14], unemployment [15]
and residing in social-economically deprived areas
[16] are predictors of a lower BC screening coverage
rate. Lack of a regular health care provider is associ-
ated with a reduced coverage rate of screening both
inside [17] and outside a BCSP [7]. Other individual
level characteristics include residential instability [18],being an immigrant [19], physical disability [20], and
having one or more chronic diseases [21]. Only a rela-
tively small amount of studies are dedicated to explor-
ation of the determinants of screening outside a BCSP.
Regular visits to a gynecologist, being employed and
low esteem of the quality of the population screening
program are associated with an increased attendance
to screening outside a BCSP [6, 7, 22]. However, these
studies only depend on self-reported data from health
surveys or focus group discussions.
There is a paucity of studies that have investigated
the determinants of screening coverage in a setting
that has BC screening in and outside BCSP. The aim of
this study therefore was to evaluate the factors associ-
ated with the coverage rate of mammography screen-
ing and factors that contribute to women’s choice of




Flanders, the most populated region of Belgium, estab-
lished a BCSP for women aged 50–69 in 2001 [5]. The
organization and implementation of mammography
screening in and outside the BCSP in Flanders have
been described in detail elsewhere [5, 23, 24]. Briefly,
in BCSP, every 2 years, eligible women aged 50–69 are
actively recruited through a personalized invitation let-
ter sent by the Center for Cancer Detection in Flanders
with a fixed time and place for a digital mammography
screening fully and directly paid by the health insur-
ance system in Flanders. The Flemish program follows
the European quality assurance guidelines [9]. Mam-
mography screening outside the context of the BCSP
can be accessed by a referral from a general practi-
tioner (GP) or a gynecologist, is not fully covered by
health insurance [5], and does not systematically in-
clude quality-control activities (e.g. double reading)
[5]. Since 2016, women who received reimbursement
for mammography in the last 2 years from the health
insurance or have been diagnosed with BC in the last
10 years in the Flemish health care system are not in-
vited for the population screening program.
Data description
Municipality level screening coverage in 2008–2016
was calculated using data from the Center for Cancer
Detection in Flanders [25]. Municipalities that have no
missing values of the number of screened and non-
screened women were included in the study. Independ-
ent variables at the municipality level of 2008–2016
were derived from the database of the Flemish provin-
cial authorities and linked to data of the screening
coverage. We included only the variables that were
Ding et al. International Journal for Equity in Health          (2020) 19:212 Page 3 of 9publicly available in order to reduce the bias that may
be induced by the selection of variables [26].
Privacy considerations
Privacy was warranted since only aggregated data were
available at municipality level and for municipalities with
less than 5 screened women overall or in one of the four
age groups (50–54, 55–59, 60–64, and 65–69), a missing
value was used.
Main outcome
The main outcome of our analysis was the screening
coverage rate inside and outside the BCSP from 2008 to
2016. The coverage rate was presented overall as a me-
dian value over all years and municipalities and stratified
by age groups and the two screening strategies.
Determinants considered
For an overview of the variables considered in the
analysis, see Table 1. Number of residents and popu-
lation density were defined as the total number of
residents and the number of residents per km2 per
municipality, respectively. Natural balance was de-
fined as the natural growth per 1000 residents per
municipality. Residential stability was indicated by the
percentage of residents having the same address as
the year before. Non-Belgian nationality was defined
as the percentage of residents without a Belgian na-
tionality per municipality. The socioeconomic status
(SES) of residents was characterized by the following
four proxy variables: (1) Average household size wasTable 1 Social demographic parameters of Flanders per municipalit
included
Population and households
number of residents (105 residents)
population density (1000 residents per km2)
natural balance (per 1000 residents)
same address as last year (compared to all residents)%
non-Belgian nationality (compared to all residents)%
average household size
Welfare and poverty (%)
women with equivalent living wages (compared to all women residents)
share of borrowers with at least one overdue loan (compared to all borrow
job seekers (compared to all residents)%
Health and handicap (%)
person with physical disability18-64y (compared to all residents in 18-64y)
diabetes (compared to all residents)
dental visit (compared to all residents)defined as the average number of residents per house-
holds as a proxy for crowded housing conditions.
(2)Women with equivalent living wages was defined as
the percentage of women with equivalent living wages
which is the minimum income awarded by the social
welfare center. (3)Share of borrowers with at least one
overdue loan was defined as the percentage of bor-
rowers with at least one overdue loan per municipal-
ity where a high percentage was considered as a
proxy for poverty; and (4)Job seekers were defined as
the percentage of unemployed residents with waiting
allowance or bridging allowance per municipality.
Health status was indicated by residents aged 18–64
with physical disability or status of diabetes, and de-
fined as the percentage of handicapped residents aged
18–64 and the percentage of residents with diabetes
recognized by the health insurance system, respect-
ively. Healthy behavior was indicated by dental visit
defined as the percentage of residents having at least
2 visits at the dentist in 2 different years within a
period of 3 calendar years per municipality.
Statistical analysis
Median value and interquartile range (IQR): p25-p75
were calculated for all continuous variables which
were not normally distributed. The annual screening
coverage rate inside and outside the BCSP was calcu-
lated as a median value over all years and municipal-
ities and presented overall and stratified by four age
groups: 50–54, 55–59, 60–64, and 65–69. To evalu-
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regression model with generalized estimating equa-
tions (GEE) was constructed to account for the cor-
relation of repeated measurements of municipality
level screening coverage rate and social demographic
parameters. In the GEE model, the dependent vari-
able was the municipality level coverage rate and the
independent variables were the municipality level
social demographic parameters as given in Table 1. A
binary variable that indicated the type of screening
strategy that the coverage rate referred to was
provided and used as an independent variable. Odds
ratios (OR) were reported with 95% confidence inter-
val (CI). The effect of social demographic parameters
was investigated by assessing a two-way interaction
between the two screening strategies and the significant
independent variables. All statistical analyses were per-
formed using R version 3.6.0, and a two-sided P < 0.05 was
considered statistically significant.
Results
We included 295 of the 308 municipalities in Flanders
that reported full data of the number of screened
women of the two screening strategies in all age
groups in 2008–2016. The median percentages of all
included social demographic parameters over all years
and municipalities are shown in Table 1.The overall
median coverage of all years and municipalities of both
screening strategies combined was 60.90%. The median
coverage rates of all years and municipalities inside
and outside the BCSP were 48.40% (IQR: 41.50–
54.40%) and 14.10% (IQR: 9.80–19.80%) respectively,
Table 2. The median coverage of screening outside the
BCSP decreased from 2008 to 2016, especially in the
youngest age group, while an increase of screening
coverage inside the BCSP was seen in all age groups,
Fig. 1.
From the univariate analysis it followed that signifi-
cantly less women were screened outside the BCSP
than inside the BCSP (OR: 0.184, 95% CI: 0.180–





50–54 year 45.40 (37.50–51.30)
55–59 year 50.10 (42.80–56.10)
60–64 year 50.10 (43.60–56.20)
65–69 year 47.80 (42.40–53.40)the BCSP was positively associated with the average
household size (OR: 1.282, 95% CI: 1.138–1.444),
while negatively associated with the percentage of
women with equivalent living wages (OR: 0.899, 95%
CI: 0.855–0.945), the percentage of unemployed job
seekers (OR: 0.961, 95% CI: 0.936–0.987) and popula-
tion density (OR: 0.918, 95% CI: 0.888–0.949).
(Table 3). After the adjustment for social demographic
parameters in the multivariate analysis, the probability
of being screened inside or outside the BCSP was only
negatively associated with average household size (OR:
0.894, 95% CI: 0.809–0.988), population density (OR:
0.929, 95% CI: 0.906–0.952), and diabetes prevalence
(OR: 0.964, 95% CI: 0.952–0.976) whereas positively
associated with the percentage of unemployed job
seekers (OR: 1.073, 95% CI: 1.051–1.095), and the per-
centage of residents with proper dental care (OR:
1.005, 95% CI: 1.003–1.007) (Table 4).
Contrary to the BCSP, the probability of being
screened outside the BCSP was positively associated with
being in a younger age group, a high population density
(OR: 2.528, 95% CI: 2.455–2.606), and a larger house-
holds size (OR: 3.797, 95% CI: 3.199–4.508), and nega-
tively associated with the diabetes prevalence (OR: 0.942,
95% CI: 0.921–0.962), the percentage of unemployed job
seekers (OR: 0.641, 95% CI: 0.624–0.658) and the per-
centage of residents with proper dental care (OR:
0.969, 95% CI: 0.967–0.972) (Table 4).Discussion
In the present study, we assessed the coverage deter-
minants of screening inside and outside the BCSP in
Flanders. A median 48.4% of women aged 50–69 are
screened by the BCSP which is significantly higher
than the 14.1% of women screened outside the pro-
gram. Working women in younger age group (50–54
years of age), and women living in crowded house-
holds with low dental care go less frequently to the
screening, and if they go, they tend to be screened
more frequently outside the context of the BCSP.): Median (P25-P75)






Fig. 1 Median (P25-P75) screening coverage rate of 295 municipalities by age groups in 2008–2016
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ing inside and outside the BCSP is within the range of
coverage levels of European countries (average: 48.2%
(range: 19.4–88.9%)) [27]. The median coverage rate
of the BCSP in Flanders of 48.4% is close to the cover-
age rate of the BCSP in countries such as France
(52.8%) [6] and Switzerland (46.7%) [7, 27] and higher
than in Serbia (38.0%) [28]. In these three countries
there is screening in and outside the context of the
BCSP. However, it is much lower than the coverage
rate of the BCSP in some western and northern
European countries like the United Kingdom (78.0%),
the Netherlands (78.5%), and Norway (72.1%) [27]
where only the BCSP is endorsed as the population
screening strategy.
From 2006 to 2016, the coverage rate of BCSP
increased while the coverage rate outside the BCSP
decreased. This effect might be explained by public
health campaigns via mass media and community
education programs [24, 29], which increased the
visibility and awareness of BCSP for the target popu-
lation and their doctors [29, 30]. A decrease in
screening coverage rate was observed from 17.50 to
11.40% for the individuals from age 50–54 to 65–69
years old in the screening outside the BCSP, whereas
this pattern was not observed for the individuals inthe BCSP. A similar pattern is also observed in coun-
tries like France [6, 31] and the United States of
America [32] where both screening strategies are
provided in large scale. A potential explanation can
be that older women are more likely to attend the
relatively fixed time and place of the BCSP than
younger working women.
We found that living in crowded households, living
in an area with high population density, and having a
low dental care are associated with a lower probability
of being screened. These three characteristics are all
indicators for a low SES. People living in areas with a
high population density tend to have a lower SES [33].
People living in crowded household are more likely to
fall into income poverty [34]. As dental care is not
fully covered by the health insurance system in Flan-
ders [35], a low dental care indicates a lower SES [36].
Similar associations are also available in the literature
regarding the increased BCSP coverage and increased
dental care [19], less crowded household condition
[14], and decreased population density [37].
Interestingly, women that are characterized by living
in an area with high population density, living in a
more crowded households, or having a low dental care
tend to go more frequently for screening outside the
BCSP. The reverse SES gradient in the use of screening
Table 3 Univariate analysis of the determinants of screening in or outside the population BC screening
Variable Crude OR (95% CI) P value
Year 1.002 (0.996–1.008) 0.534
Age group < 0.001
50–54 year ref
55–59 year 1.034 (0.993–1.077)
60–64 year 1.014 (0.973–1.057)
65–69 year 0.933 (0.894–0.973)
BC screening < 0.001
Population BC screening ref
Non-population BC screening 0.184 (0.180–0.189)
Population and households
number of residents (105 residents) 0.962 (0.941–0.983) < 0.001
population density (1000 residents per km2) 0.918 (0.888–0.949) < 0.001
natural balance (per 1000 residents) 0.996 (0.990–1.002) 0.194
same address as last year (compared to all residents) 1.024 (1.013–1.035) < 0.001
non-Belgian nationality (compared to all residents) 0.996 (0.993–0.999) 0.016
average household size 1.282 (1.138–1.444) < 0.001
Welfare and poverty
women with equivalent living wages (compared to all women) 0.899 (0.855–0.945) < 0.001
share of borrowers with at least one overdue loan (compared to all borrowers) 0.970 (0.958–0.982) < 0.001
job seekers (compared to all residents) 0.961 (0.936–0.987) 0.004
Health and handicap
physical disability18-64y (compared to all residents of 18-64y) 1.003 (0.986–1.021) 0.701
diabetes (compared to all residents) 0.972 (0.954–0.991) 0.003
dental visit (compared to all residents) 1.009 (1.006–1.012) < 0.001
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where both screening strategies coexist [6, 7, 37]. An
explanation for this phenomenon is that women with a
higher SES are more likely to have a higher level of
health literacy [38]. For these women, information
regarding the importance of mammography screening
and the systematic quality control is more likely to mo-
tivate them to participate in the BCSP [5] [29]. Another
explanation is that poor employed women could have
less flexible working time, which can conflict with the
fixed working time of organized screening units [6, 7,
37, 39]. It has also been mentioned that areas with a
higher population density have a lower population BC
screening capacity (defined as the number of mammog-
raphy facilities per 10,000 women) [40] and that in
these areas there are more private clinics for opportunistic
screening [37]. As a lower capacity of screening units can
induce a longer waiting time and therefore a lower satis-
faction of screening experience [5], low SES women living
in these areas might be more likely to have negative
screening experience and as a consequence prefer to
go for screening outside the BCSP [22].The strength of this study is that we examined deter-
minants of coverage rate of screening in and outside
the BCSP with longitudinal administrative data instead
of self-reported screening uptake, which may induce
recall bias. For that, regular collected and maintained
administrative data of screening coverage outside the
BCSP were applied. This enabled us to evaluate the
determinants of the two coexisting screening strategies
for BC and to better understand which further efforts
are needed to improve the coverage of the BCSP in
Flanders. However, our study had some limitations as
well. First, a limitation of this study was the use of
aggregated data, which reduced the options to evaluate
correlation structures in the data [41]. Similarly, due to
the aggregated data, a variation of coverage rate and
the associated determinants within a municipality can
be concealed. However, the association between the
determinants and screening uptake in our study is con-
sistent with other studies that applied neighborhood or
individual level factors [13, 18, 19]. Second, proxy vari-
ables for SES were applied instead of income which
can directly characterize SES of women. However, the
Table 4 Multivariable analysis of the determinants of screening in or outside the population BC screening
Variable Model 1a Model 2b
Adjusted OR (95% CI) P value Adjusted OR (95% CI) P value
Age group < 0.001 < 0.001
50–54 year ref ref
55–59 year 1.039 (1.015–1.065) 1.207 (1.179–1.235)
60–64 year 1.018 (0.994–1.042) 1.217 (1.190–1.244)
65–69 year 0.928 (0.907–0.949) 1.142 (1.117–1.167)
BC screening < 0.001 < 0.001
Population BC screening ref ref
Non-population BC screening 0.224 (0.220–0.229) 0.303 (0.295–0.312)
Population and households
number of residents (105 residents) 0.983 (0.965–1.001) 0.059 0.996 (0.985–1.007) 0.444
population density (1000 residents per km2) 0.929 (0.906–0.952) < 0.001 0.647 (0.634–0.660) < 0.001
same address as last year (compared to all residents) 1.008 (0.998–1.018) 0.123 1.005 (0.995–1.015) 0.309
non-Belgian nationality (compared to all residents) 1.0005 (0.9984–1.0025) 0.654 0.9997 (0.9982–1.0012) 0.719
average household size 0.894 (0.809–0.988) 0.028 0.580 (0.522–0.645) < 0.001
Welfare and poverty
women with equivalent living wages
(compared to all women)
0.972 (0.934–1.012) 0.164 0.987 (0.947–1.029) 0.532
share of borrowers with at least one overdue loan
(compared to all borrowers)
0.989 (0.976–1.002) 0.092 0.989 (0.978–1.001) 0.067
job seekers (compared to all residents) 1.073 (1.051–1.095) < 0.001 1.250 (1.226–1.273) < 0.001
Health can handicap
diabetes (compared to all residents) 0.964 (0.952–0.976) < 0.001 0.985 (0.973–0.997) 0.016
dental visit (compared to all residents) 1.005 (1.003–1.007) < 0.001 1.016 (1.015–1.018) < 0.001
Interaction terms
age group × BC screening < 0.001
NPS × 50–54 year ref
NPS × 55–59 year 0.668 (0.642–0.694)
NPS × 60–64 year 0.612 (0.589–0.636)
NPS × 65–69 year 0.554 (0.533–0.576)
NPS × population density 2.528 (2.455–2.606) < 0.001
NPS × average household size 3.797 (3.199–4.508) < 0.001
NPS × job seekers 0.641 (0.624–0.658) < 0.001
NPS × status of diabetes 0.942 (0.921–0.962) < 0.001
NPS × dental visit 0.969 (0.967–0.972) < 0.001
amodel 1: multivariable regression model including all significant covariates of the univariate regression
bmodel 2: multivariable regression model including two-way interaction terms between screening strategies and the significant covariates in model 1
NPS Non-population BC screening
Ding et al. International Journal for Equity in Health          (2020) 19:212 Page 7 of 9proxy variables used are commonly applied and the
magnitude and direction of the association between
variables is consistent with the literature [6, 14, 18].
Conclusion
A sizeable part of women attend screening outside
the BCSP in Flanders. Women with low SES that arecharacterized by younger age, living in a high popula-
tion density area, living in crowded households, or
having low dental care, go less frequently to screen-
ing. If they go to screening, they are more likely to
be screened outside the BCSP. Further efforts targeted
on this group of women are needed to improve the
coverage rate of the BCSP in Flanders.
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practitioner; SES: Socioeconomic status; IQR: Interquartile range;
GEE: Generalized estimating eqs.; OR: Odds ratios; CI: Confidence interval
Acknowledgements
L. Ding is supported by the China Scholarship Council (CSC) PhD scholarship
(file NO. 201808320439) for his research and study at the University of
Groningen, University Medical Center Groningen, Groningen, The
Netherlands. The scholarship had no role in study design, data analysis and
interpretation, the writing of the manuscript and the decision to submit the
article for publication.
Authors’ contributions
L. Ding: Conceptualization, Methodology, Writing- Original draft preparation.
S. Jidkova: Data curation, Writing- Reviewing and Editing, Validation. M.J.W.
Greuter: Conceptualization, Methodology, Writing- Reviewing and Editing.
G.H. de Bock: Supervision. K. Van Herck: Writing- Reviewing and Editing,
Validation. M. Goossens: Writing- Reviewing and Editing, Validation. P.
Martens: Writing- Reviewing and Editing, Validation. G. Van Hal:
Conceptualization, Methodology, Writing- Reviewing and Editing. The
author(s) read and approved the final manuscript.
Funding
None.
Availability of data and materials
Breast cancer screening coverage dataset is available at https://
bevolkingsonderzoek.incijfers.be/, variables regarding the determinants of
screening coverage can be requested by contacting the Center for Cancer
Detection in Flanders at www.bevolkingsonderzoek.be.
Ethics approval and consent to participate
Not applicable.
Consent for publication




1Department of Epidemiology, University Medical Center Groningen,
University of Groningen, Groningen, The Netherlands. 2Department of Social
Epidemiology and Health Policy, University of Antwerp, Antwerp, Belgium.
3Department of Public Health and Primary Care, Ghent University, Ghent,
Belgium. 4Center for Cancer Detection, Flanders, Belgium. 5Department of
Radiology, University Medical Center Groningen, University of Groningen,
Groningen, The Netherlands. 6Department of Robotics and Mechatronics,
University of Twente, Enschede, The Netherlands.
Received: 13 April 2020 Accepted: 11 November 2020
References
1. Bray F, et al. Global Cancer Statistics 2018: GLOBOCAN estimates of
incidence and mortality worldwide for 36 cancers in 185 countries: global
Cancer statistics 2018. CA Cancer J Clin. 2018;68(6):394–424.
2. International Agency for Research on Cancer. CANCER TODAY: Population
fact sheets-Belgium, http://gco.iarc.fr/today/data/factsheets/populations/56-
belgium-fact-sheets.pdf; 2018[Accessed 3 February 2020].
3. Myers ER, et al. Benefits and harms of breast Cancer screening: a systematic
review. JAMA. 2015;314(15):1615–34.
4. Lauby-Secretan B, et al. Breast-Cancer screening — viewpoint of the IARC
working group. N Engl J Med. 2015;372(24):2353–8.
5. Goossens M, et al. Quantifying independent risk factors for failing to
rescreen in a breast cancer screening program in Flanders, Belgium. Prev
Med. 2014;69:280–6.
6. Duport N. Characteristics of women using organized or opportunistic breast
cancer screening in France. Analysis of the 2006 French health, health care
and insurance survey. Rev Epidemiol Sante Publique. 2012;60(6):421–30.7. Eichholzer M, et al. Breast cancer screening attendance in two Swiss regions
dominated by opportunistic or organized screening. BMC Health Serv Res.
2016;16(1):519.
8. Massat N, et al. Variation in cervical and breast cancer screening coverage in
England: a cross-sectional analysis to characterise districts with atypical
behaviour. BMJ Open. 2015;5:e007735.
9. Perry N, et al. European guidelines for quality assurance in breast cancer
screening and diagnosis. Fourth edition--summary document. Ann Oncol.
2008;19(4):614–22.
10. OECD.Stat, Health Care Utilisation. https://stats.oecd.org/Index.
aspx?DataSetCode=HEALTH_PROC. Accessed 3 Feb 2020.
11. Annual Report Population Screening for Cancer 2018. Center for Cancer
detection-Belgian Cancer registry, Bruges, 2018.
12. Sarma EA. Barriers to screening mammography. Health Psychol Rev. 2015;
9(1):42–62.
13. Katz D, et al. Patient and physician characteristics affect adherence to
screening mammography: a population-based cohort study. PLoS One.
2018;13(3):12.
14. Zackrisson S, et al. Non-attendance in breast cancer screening is associated
with unfavourable socio-economic circumstances and advanced carcinoma.
Int J Cancer. 2004;108(5):754–60.
15. Jensen LF, et al. Identifying specific non-attending groups in breast cancer
screening - population-based registry study of participation and socio-
demography. BMC Cancer. 2012;12:9.
16. Smith D, et al. The breast cancer paradox: a systematic review of the
association between area-level deprivation and breast cancer screening
uptake in Europe. Cancer Epidemiol. 2019;60:77–85.
17. Pornet C, et al. Socioeconomic and healthcare supply statistical
determinants of compliance to mammography screening programs: a
multilevel analysis in Calvados, France. Cancer Epidemiol. 2010;34(3):309–15.
18. Zackrisson S, et al. Social predictors of non-attendance in an urban
mammographic screening programme: a multilevel analysis. Scand J Public
Health. 2007;35(5):548–54.
19. von Euler-Chelpin M, et al. Socio-demographic determinants of participation
in mammography screening. Int J Cancer. 2008;122(2):418–23.
20. Zha N, et al. Beyond Universal Health Care: Barriers to Breast Cancer
Screening Participation in Canada. J Am Coll Radiol. 2019;16(4 Pt B):
570–9.
21. Miles RC, et al. Chronic medical illness as a risk factor for poor
mammography screening adherence. J Women's Health (Larchmt). 2019;
28(10):1378–83.
22. Ferrat E, et al. Understanding barriers to organized breast cancer screening
in France: women's perceptions, attitudes, and knowledge. Fam Pract. 2013;
30(4):445–51.
23. Van Oyen H, Verellen W. Breast cancer screening in the Flemish region,
Belgium. Eur J Cancer Prev. 1994;3(Suppl 1):7–12.
24. Willems B, Bracke P. The impact of regional screening policies on the
diffusion of cancer screening participation in Belgium: time trends in
educational inequalities in Flanders and Wallonia. BMC Health Serv Res.
2018;18(1):943.
25. Goossens M, et al. Flemish breast cancer screening programme: 15 years of
key performance indicators (2002-2016). BMC Cancer. 2019;19(1):1012.
26. Portnov BA, Dubnov J, Barchana M. On ecological fallacy, assessment errors
stemming from misguided variable selection, and the effect of aggregation
on the outcome of epidemiological study. J Expo Sci Environ Epidemiol.
2007;17(1):106–21.
27. Giordano L, et al. Mammographic screening programmes in Europe:
organization, coverage and participation. J Med Screen. 2012;19(Suppl
1):72–82.
28. Jovicevic A, et al. Factors influencing participation in breast cancer
opportunistic screening in Belgrade, Serbia. J Buon. 2018;23(3):706–12.
29. Wouters M, Vleminckx F, Van Hal G. How to reach a higher participation
rate for breast cancer screening in Flanders? Arch Public Health Brussels.
2006;64(2/3):109–21.
30. Rogers, E.M. Diffusion of innovations.5th ed. New York: Free Press; 2003.
31. Ouedraogo S, et al. Breast cancer screening programmes: challenging the
coexistence with opportunistic mammography. Patient Educ Couns. 2014;
97(3):410–7.
32. Beaber EF, et al. Multilevel predictors of continued adherence to breast
cancer screening among women ages 50-74 years in a screening
population. J Women's Health. 2019;28(8):1051–59.
Ding et al. International Journal for Equity in Health          (2020) 19:212 Page 9 of 933. Zhu Z, et al. The impact of urban characteristics and residents’ income on
commuting in China. Transp Res Part D: Transp Environ. 2017;57:474–83.
34. Melki IS, et al. Household crowding index: a correlate of socioeconomic
status and inter-pregnancy spacing in an urban setting. J Epidemiol
Community Health. 2004;58(6):476.
35. Lambert MJ, et al. Socioeconomic inequalities in caries experience, care
level and dental attendance in primary school children in Belgium: a cross-
sectional survey. BMJ Open. 2017;7(7):e015042.
36. Kailembo A, et al. Income and wealth as correlates of socioeconomic
disparity in dentist visits among adults aged 20 years and over in the
United States, 2011–2014. BMC Oral Health. 2018;18(1):147.
37. Jensen A, et al. Do nonattenders in mammography screening programmes
seek mammography elsewhere? Int J Cancer. 2005;113(3):464–70.
38. Guo Y, et al. Health literacy: a pathway to better oral health. Am J Public
Health. 2014;104(7):e85–91.
39. Collie-Akers VL, et al. Assessment of characteristics of capacity among breast
cancer screening facilities. J Community Health. 2012;37(3):626–31.
40. Elkin EB, et al. Changes in the availability of screening mammography, 2000-
2010. Cancer. 2013;119(21):3847–53.
41. Russo L, Beauguitte L. Aggregation level matters: evidence from French
electoral data. Qual Quant. 2014;48(2):923–38.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
